The harsh conditions incurred during cancer treatment (chemotherapy and radiation) has been correlated with the increase of inflammatory mediators such as C-reactive protein (CRP) and interleukin (IL)-6, which can promote depression [37]. This evidence concerns the gene IL6 and depressive symptom measurement.